Interstitial Lung Disease (ILD) is a chronic condition marked by lung inflammation and scarring that makes breathing ...

Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis: Austin, Texas Wednesday, September 25, 2024, 15:00 Hrs ...

Desaturation during the 6-minute walk test is a significant predictive factor for mortality in patients with idiopathic pulmonary fibrosis.

Pulmonary Fibrosis Awareness Month may be coming to a close, but it's important to keep the momentum going, columnist Sam Kirton says.

Clinical trial results shared by Boehringer Ingelheim and Insilico Medicine showed improvement in idiopathic pulmonary ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five presentations and one poster across its commercial and development portfolio will be presented ...

Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...

On September 17, 2024, the lord blessed Randall “Randy” Scott Hall a much-deserved poetic exit, after an acute exacerbation of idiopathic pulmonary fibrosis (IPF), at Saint Joesph Hospital in Denver, ...

Insilico Medicine has made headlines for discovering novel compounds for fibrosis using AI-generated models, further ...

A new statistical technique developed by a researcher at the Texas A&M University School of Public Health and colleagues ...

A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...

ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...